Altimmune Cash Flow Statement (2010-2026) | ALT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-24.83M	-33.51M	-5.38M	-19.54M	-20.13M	-23.52M	51.09M	-20.09M	-16.17M	-20.67M	-8.89M	-24.39M	-24.64M	-22.84M	-23.18M	-19.57M	-22.15M	-19.01M	57.89M	-22.56M
Depreciation and Depletion (Quarter)	0.07M	0.10M	0.20M	0.10M				0.12M	0.12M	0.12M	0.14M	0.11M	0.06M	0.04M	-0.01M	0.03M	0.03M	0.03M	0.01M	0.02M
Share-based Compensation (Quarter)	1.49M	1.50M	1.32M	2.03M	2.05M	2.13M	1.89M	2.67M	2.79M	2.71M	2.47M	3.65M	4.31M	3.08M	3.35M	4.01M	3.57M	3.55M	4.94M	3.38M
Deferred Taxes (Quarter)																-0.68M
Gains from Sales and Divestitures (Quarter)			0.00M		0.04M	0.05M	0.07M		0.10M	0.10M	0.12M		0.29M	0.29M	0.29M			0.27M	0.29M
Gains from Investment Securities (Quarter)	0.01M	2.61M	-0.86M	3.46M	3.36M	3.53M	-0.30M	4.48M	4.83M	5.08M	0.04M	6.54M	6.28M	0.35M	0.00M	0.04M	8.10M	8.66M	0.03M	0.69M
Asset Writedowns and Impairment (Quarter)	8.07M	0.03M	3.30M																	0.71M
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)	17.16M	0.98M	8.46M	1.27M	0.00M	0.02M	25.72M	0.03M	0.73M	2.26M	16.92M	15.08M	3.30M	4.16M	5.84M	2.50M	4.32M	4.50M	0.88M	0.51M
Cash from Operations (Quarter)	-18.93M	-17.77M	-21.97M	-13.53M	-16.70M	-15.05M	-17.31M	-19.41M	-19.38M	-20.49M	-16.53M	-16.36M	-18.11M	-27.12M	-18.27M	-16.84M	-19.35M	-11.90M	-19.45M	-20.94M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Amortizatization of Intangibles (Quarter)								0.48M	0.63M	0.67M	0.69M	0.98M	1.07M	0.98M	0.82M	0.69M	0.43M	0.20M	0.91M	0.87M
Amortization of Deferred Charges (Quarter)																		0.11M	0.19M	0.22M
Depreciation & Amortization (CF) (Quarter)	0.07M	0.28M	0.12M	0.12M	0.05M	-0.14M	-0.24M	-0.36M	-0.51M	-0.55M	0.14M	0.11M	0.06M	0.04M	-0.01M	0.03M	0.03M	0.03M	0.01M	0.02M
Change in Working Capital
Change in Receivables (Quarter)	-0.10M	-3.13M	-1.15M	-0.24M	0.00M	0.44M	-0.46M	0.08M	-0.12M	0.74M	0.23M	-0.80M	0.12M	0.00M	0.12M	-0.04M	-0.19M	0.52M	0.37M	0.45M
Change in Account Payables (Quarter)	1.00M	-1.42M	2.03M	0.17M	0.67M	-1.45M	3.38M	0.43M	-1.20M	-0.99M	-0.98M	1.69M	-1.07M	-1.55M	-0.92M	0.87M	-0.23M	3.95M	-2.09M	-1.19M
Change in Accured Expenses (Quarter)	-1.86M	10.97M	-9.21M	2.66M	-1.53M	6.43M	-2.16M	-2.83M	-2.10M	1.62M	1.42M	-2.75M	5.01M	-4.74M	2.37M	-1.70M	-0.36M	0.10M	4.35M	-2.49M
Change in Taxes (Quarter)	-1.01M	2.59M
Investing Activities
Capital Expenditures (Quarter)	7.69M	0.07M	0.15M	0.01M	0.02M	0.06M	0.04M	0.05M	-0.00M										0.00M	0.02M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)	0.08M	0.04M	0.01M
Change in Acquisitions & Divestments (Quarter)	32.80M	18.69M	25.02M					34.56M	26.00M	15.98M	25.87M	14.00M	19.50M	27.00M	26.84M	38.04M	105.55M		9.40M	39.62M
Cash from Investing Activities (Quarter)	25.08M	18.41M	24.87M	-0.01M	-48.97M	-25.40M	0.98M	13.30M	3.99M	4.40M	-7.96M	-39.52M	-3.70M	1.20M	13.63M	-5.10M	101.11M	-149.32M	-79.16M	-3.69M
Financing Activities
Other financing activities (Quarter)																0.00M	0.40M	0.32M	0.35M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)																			20.00M
Long-Term Debt Repayments (Quarter)
Short-Term Debt issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)		52.25M	12.46M	0.11M	24.22M	-23.47M	-0.69M	0.06M			86.54M	0.16M	0.01M	0.13M	9.69M	0.17M	-0.16M	112.08M	-112.05M	0.18M
Preferred Shares Issued (Quarter)
Preferred Shares Repurchased (Quarter)
Dividend Payments
Dividends Paid - Common (Quarter)
Misc.
Cash from Financing Activities (Quarter)	18.02M	0.12M	12.54M	3.18M	21.58M	32.06M	-0.04M	-0.30M	13.06M	0.59M	72.75M	-0.26M	-0.05M	0.27M	10.09M	34.12M	52.24M	39.35M	81.13M	78.47M
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	24.17M	0.76M	15.44M	-10.35M	-44.09M	-8.39M	-16.37M	-6.41M	-2.33M	-15.50M	48.26M	-56.14M	-21.85M	-25.65M	5.45M	12.18M	134.00M	-121.87M	-17.48M	53.84M
Free Cash Flow (Quarter)	-26.62M	-17.84M	-22.11M	-13.54M	-16.72M	-15.11M	-17.34M	-19.46M	-19.38M	-20.49M	-16.53M	-16.36M	-18.11M	-27.12M	-18.27M	-16.84M	-19.35M	-11.90M	-19.45M	-20.96M
Net Cash Flow (Quarter)	24.17M	0.76M	15.44M	-10.35M	-44.09M	-8.39M	-16.37M	-6.41M	-2.33M	-15.50M	48.26M	-56.14M	-21.85M	-25.65M	5.45M	12.18M	134.00M	-121.87M	-17.48M	53.84M

Research Tools

Developers

Altimmune Cash Flow Statement (2010-2026) | ALT

Research Tools

Developers

Altimmune Cash Flow Statement (2010-2026) | ALT

Create an account

Sign In

Reset Password